Agilus Diagnostics Cuts Cancer Genomic Profiling Time from 30 Days to 4 Days

Powered by advanced next-generation sequencing (NGS) technology, the test provides oncologists with rapid, actionable insights to guide personalized therapies.

Agilus Diagnostics, a subsidiary of Fortis Healthcare Ltd., has launched the AgilusEDGE Comprehensive Genomic Profile (CGP) Rapid, offering genomic profiling of over 500 cancer-related genes in just four working days.

Traditionally, such profiling takes up to 30 days, often delaying critical treatment decisions.

Powered by advanced next-generation sequencing (NGS) technology, the test provides oncologists with rapid, actionable insights to guide personalized therapies. This positions Agilus Diagnostics as the first commercial laboratory in India to deliver such expedited multi-gene profiling.

Dr Anand K, Managing Director & CEO at Agilus Diagnostics, said, “By bringing down the turnaround time for comprehensive genomic profiling from nearly a month to just four working days, Agilus Diagnostics has taken a decisive leap forward in cancer care. Being the first lab chain in India to introduce this capability, we are not only redefining industry benchmarks but also ensuring that patients and oncologists have faster access to critical insights when every day matters. This breakthrough reflects our commitment to making advanced, precision diagnostics-led personalized medicine a reality for patients across India."

The AgilusEDGE CGP Rapid offers:

• Profiling of 500+ genes relevant to targeted therapies and precision oncology.

• Turnaround time of four working days, compared with the industry standard of several weeks.

• Compatibility with formalin-fixed paraffin-embedded (FFPE) tissue, ensuring integration into existing diagnostic workflows.

Advanced NGS Technology Powers Rapid Insights

The launch strengthens Agilus Diagnostics’ role in advancing cancer care by shortening the gap between diagnosis and treatment, which could improve patient outcomes. By providing faster access to genomic information, oncologists can tailor treatment plans more effectively and promptly.

Stay tuned for more such updates on Digital Health News